BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1848639)

  • 1. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer.
    Munck JN; Cvitkovic E; Piekarski JD; Benhamou E; Recondo G; Bachouchi M; Tellez-Bernal E; Luboinski B; Eschwege F; Wibault P
    J Natl Cancer Inst; 1991 Apr; 83(8):569-75. PubMed ID: 1848639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent.
    Wang HM; Ng SH; Wang CH; Liaw CC; Tsai MH; Lai GM
    Cancer; 1996 Nov; 78(9):1972-9. PubMed ID: 8909319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cervical lymph nodes density evaluated by contrasted computer tomography in head and neck squamous cell carcinoma treated with hyperthermia and radiotherapy.
    Amichetti M; Zurlo A; Cristoforetti L; Valdagni R
    Int J Hyperthermia; 2000; 16(6):539-47. PubMed ID: 11129264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: a prospective validation.
    Janot F; Cvitkovic E; Piekarski JD; Sigal R; Armand JP; Bensmaine A; Luboinski B
    Head Neck; 1993; 15(3):222-9. PubMed ID: 8491586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
    Jaju S; Gupta SK; Pandey S; Singh V
    J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer.
    Kurek R; Kalogera-Fountzila A; Muskalla K; Dafni U; Schnabel T; Kober B; Röddiger S; Martin T; Fountzilas G; Zamboglou N
    Strahlenther Onkol; 2003 May; 179(5):292-7. PubMed ID: 12740655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.
    Grabenbauer GG; Steininger H; Meyer M; Fietkau R; Brunner T; Heinkelmann P; Hornung J; Iro H; Spitzer W; Kirchner T; Sauer R; Distel L
    Radiother Oncol; 1998 May; 47(2):175-83. PubMed ID: 9683366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
    Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.
    Nevens D; Vantomme O; Laenen A; Hermans R; Nuyts S
    Cancer Imaging; 2017 Feb; 17(1):8. PubMed ID: 28241854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
    Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
    AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
    Nishimura G; Yabuki K; Hata M; Komatsu M; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
    Int J Clin Oncol; 2016 Aug; 21(4):658-667. PubMed ID: 26710795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
    Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
    Nayak JV; Walvekar RR; Andrade RS; Daamen N; Lai SY; Argiris A; Smith RP; Heron DE; Ferris RL; Johnson JT; Branstetter BF
    Laryngoscope; 2007 Dec; 117(12):2129-34. PubMed ID: 17921898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
    Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.